Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epsilon Securities is a boutique investment bank and FINRA-registered broker-dealer that provides specialized financial advisory services to the life sciences, biotechnology, and healthcare industries. The firm focuses on assisting emerging and mid-sized companies with mergers and acquisitions (M&A), private placements of equity and debt, and strategic corporate finance. By combining deep sector expertise with financial execution capabilities, Epsilon Securities helps healthcare innovators secure capital and execute strategic transactions to drive growth and clinical advancement. The firm is particularly noted for its work with companies in the biopharmaceutical and medical technology sectors, often providing the transactional support necessary for complex licensing and partnership deals. Epsilon Securities operates as a strategic partner to its clients, leveraging a broad network of institutional investors and industry contacts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epsilon Securities.